Male Infertility Treatment Market Size, Share, And Growth Report 2032

Male Infertility Treatment Market Size

Zion Market Research has published a report on the global Male Infertility Treatment Market, estimating its value at USD 4.20 Billion in 2023, with projections indicating that it will reach USD 6.54 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.04% over the forecast period 2024-2032.

The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Male Infertility Treatment Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Male Infertility Treatment Market: Overview     

Reproduction is a simple and natural experience for most couples. However, for some cases, it becomes very difficult to conceive. Male infertility is a condition when the adult male is unable to make a fertile female pregnant after orgasm. It can occur due to low sperm count, the presence of less motile sperm, etc. Hypothalamus, pituitary gland and testis play a very important role in maintaining male fertility by controlling nerve signals and hormonal balance. The exact cause of male infertility is not known. But various causes associated with male infertility are smoking, excess alcohol consumption, obesity, stress, environmental toxins.

Globally, male infertility treatment market has been accelerated by increasing incidence of male infertility cases across the globe. Moreover, torpid lifestyle, increasing age, and environmental effects are the key factors responsible for increasing growth of male infertility market. However, due to emotional impact, discontinuation of treatment and social taboo are such limitations which directly affects the growth of male infertility treatment market. Nonetheless, medical tourism, awareness, low-cost treatment and ongoing research and development in healthcare sector technologies is expected to drive the growth avenues for the market over the years.

COVID-19 Impact Analysis

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. The industry is responding to COVID-19 with immediate changes designed to ensure the uninterrupted production of necessary devices while keeping workers safe. The manufacturers and government are working together to understand the need, changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the impact of significant interventions of governments. Given the importance to all to the economic development of cities, countries, and regions, the broader impact of COVID-19 on the worldwide economy is enormous.

Male Infertility Treatment Market: Growth Factors

Continuous progress R&D along with low-cost treatment in the healthcare industry is likely to open growth opportunities for the development male infertility treatment market over the forecast period. For instance, in June 2018, the BJU International study discovered that a combination of CC (clomiphene citrate) and AZ (anastrozole) therapy shows potential in male infertility treatment, thereby boosting the male infertility treatment market.

Male Infertility Treatment Market: Segmentation

Based on techniques, the global market for male infertility treatment is bifurcated into five types: DNA fragmentation, oxidative stress analysis, sperm penetration, microscopic analysis, sperm agglutination and others. DNA fragmentation accounted for the largest market share in terms of revenue and is also expected to have the highest CAGR during the forecast period. This is due to the accuracy level of the test. This test identifies the level of infertility by measuring the level of DNA damage.

Request Free Sample

Male Infertility Treatment Market: Report Scope

Male Infertility Treatment Market: Regional Analysis

Region-wise, North America was the dominating area in 2016 for male infertility treatment market in terms of income owing to the accessibility of computer-guided technologically advanced screening tests. Moreover, lifestyle-associated factors such as stress, smoking, and obesity have become very common in European nations and the U.S., boosting the male infertility treatment market. The male infertility treatment market has the huge growth avenues in emerging regions such as Latin America and Asia Pacific owing to the increased disposable income, public awareness, healthcare infrastructure, and government initiatives.

Request Free Sample

Male Infertility Treatment Market: Competitive Players

The key companies operating in the Male Infertility Treatment market include:

• Pharmaceutical Co. Ltd
• Intas Pharmaceuticals Ltd.
• Access Pharmaceuticals Inc.
• Cordex Pharma Inc.
• Pantarhei Bioscience B
• Halotech DNA SL
• Merck Serono
• Andrology Solutions
• SCSA diagnostics

The global Male Infertility Treatment Market is segmented as follows:

By Male Technique

• DNA fragmentation
• Oxidative stress analysis
• Sperm penetration
• Microscopic analysis
• Sperm agglutination
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa